The PPARγ ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice

Autor: Hwang, Jinah, Kleinhenz, Dean J., Rupnow, Heidi L., Campbell, Adam G., Thulé, Peter M., Sutliff, Roy L., Hart, C. Michael
Zdroj: In Vascular Pharmacology 2007 46(6):456-462
Databáze: ScienceDirect